Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages

A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages

Thumbnail Image
Download
Name

nihms646919.pdf

Size

2.59 MB

Format

Adobe PDF

Checksum (MD5)

4ee7c357d7cc061f7cf770bd820d644c

Download all files submitted through automated deposit
sword-2018-07-12.original.zip (2.05 MB)
Author(s)
Clauser, Karl R.
•
Fröse, Julia
•
Ye, Xin
•
Eaton, Elinor Ng
•
Reinhardt, Ferenc
•
Donnenberg, Vera S.
•
Bhargava, Rohit
•
Carr, Steven A.
•
Lu, Haihui
•
Tam, Wai Leong
more
Date Issued
September 2014
Journal
Nature Cell Biology
Publisher
Springer Nature
Citation
Lu, Haihui et al. “A Breast Cancer Stem Cell Niche Supported by Juxtacrine Signalling from Monocytes and Macrophages.” Nature Cell Biology 16, 11 (September 2014): 1105–1117 © 2014 Macmillan Publishers Limited
Version
Author's final manuscript
Abstract
The cell-biological program termed the epithelial-mesenchymal transition (EMT) confers on cancer cells mesenchymal traits and an ability to enter the cancer stem cell (CSC) state. However, the interactions between CSCs and their surrounding microenvironment are poorly understood. Here we show that tumour-associated monocytes and macrophages (TAMs) create a CSC niche through juxtacrine signalling with CSCs. We performed quantitative proteomic profiling and found that the EMT program upregulates the expression of CD90, also known as Thy1, and EphA4, which mediate the physical interactions of CSCs with TAMs by directly binding with their respective counter-receptors on these cells. In response, the EphA4 receptor on the carcinoma cells activates Src and NF-κ B. In turn, NF-κ B in the CSCs induces the secretion of a variety of cytokines that serve to sustain the stem cell state. Indeed, admixed macrophages enhance the CSC activities of carcinoma cells. These findings underscore the significance of TAMs as important components of the CSC niche.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Ludwig Center for Molecular Oncology (Massachusetts Institute of Technology)
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
http://creativecommons.org/licenses/by-nc-sa/4.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/116951
DOI of Published Version
https://doi.org/10.1038/NCB3041
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.